Accord Healthcare is voluntarily recalling 1 lot of Daptomycin for Injection 500mg/vial, and Daptomycin for Injection 350mg/vial to the consumer level due to a product mix-up. According to a product ...

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today it has received FDA approval for Daptomycin for Injection and the product is available immediately for customers in the United States ...

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today it has introduced Daptomycin for Injection in the United States. Daptomycin for Injection, an antibiotic, is a generic alternative to ...

Accord Healthcare, Inc. is voluntarily recalling a single lot of Daptomycin for Injection 500 mg/vial, and Daptomycin for Injection 350 mg/vial product contained in cartons imprinted with lot # ...

One lot of an injection medicine for serious skin infections and staph bloodstream infections has been recalled for “visible particulates.” After Mylan found that in a dose of Daptomycin for Injection ...

HERTFORDSHIRE, England and PITTSBURGH, July 7, 2020 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) today announced that its U.S.-based Mylan Institutional LLC business is conducting a voluntary nationwide ...

According to Mylan, the administration of the recalled product may lead to “serious adverse events including, but not limited to, local irritation, vasculitis/phlebitis, antigenic or allergic ...

Mylan N.V. (NASDAQ: MYL) today announced that its U.S.-based Mylan Institutional LLC business is conducting a voluntary nationwide recall to the consumer level of one lot of Daptomycin for Injection, ...

* MYLAN NV - TO DATE, CO HAS NOT RECEIVED ANY REPORTS OF ADVERSE EVENTS RELATED TO DAPTOMYCIN FOR INJECTION RECALL Source text for Eikon: Further company coverage: ...